Steady-state pharmacokinetics of abacavir in plasma and intracellular carbovir triphosphate following administration of abacavir at 600 milligrams once daily and 300 milligrams twice daily in human immunodeficiency virus-infected subjects.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples